{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:51:52Z","timestamp":1780393912891,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nbd.2022.105881","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T11:46:04Z","timestamp":1664797564000},"page":"105881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1"],"prefix":"10.1016","volume":"174","author":[{"given":"Angelina","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Proteau-Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Near","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C.N.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.E.","family":"Edden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lipp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artuela","family":"\u00c7aku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acn3.288","article-title":"A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I","volume":"3","author":"Bearden","year":"2016","journal-title":"Ann. Clin. Translat. Neurol."},{"issue":"13","key":"10.1016\/j.nbd.2022.105881_bb0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/neu.20327","article-title":"ERK\/MAPK pathway regulates GABAA receptors","volume":"66","author":"Bell-Horner","year":"2006","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105881_bb0015","first-page":"223","article-title":"Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome","volume":"92","author":"Berry-Kravis","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2015.03.042","article-title":"The GABAA receptor as a therapeutic target for neurodevelopmental disorders","volume":"86","author":"Braat","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1866-1955-5-20","article-title":"Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study","volume":"5","author":"Bruno","year":"2013","journal-title":"J. Neurodev. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2022.105881_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1469-8749.2009.03523.x","article-title":"Genetic causes of syndromic and non-syndromic autism","volume":"52","author":"Caglayan","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2022.105881_bb0035","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/ajmg.a.36750","article-title":"Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study","volume":"164","author":"\u00c7aku","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamapsychiatry.2015.3127","article-title":"Multimodal applications of transcranial magnetic stimulation for circuit-based psychiatry","volume":"73","author":"Camprodon","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bb0045","article-title":"Magnetic brain stimulation: the silent period after the motor evoked potential","volume":"42","author":"Cantello","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1152\/jn.00782.2009","article-title":"Late cortical disinhibition in human motor cortex: a triple-pulse transcranial magnetic stimulation study","volume":"103","author":"Cash","year":"2010","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.nbd.2022.105881_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.brs.2017.01.470","article-title":"Characterisation of glutamatergic and GABAA mediated neurotransmission in motor and dorsolateral prefrontal cortex using paired-pulse TMS-EEG","volume":"10","author":"Cash","year":"2017","journal-title":"Brain Stimulat."},{"issue":"11","key":"10.1016\/j.nbd.2022.105881_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2020.08.016","article-title":"Motor cortical excitability and plasticity in patients with neurofibromatosis type 1","volume":"131","author":"Castricum","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"C","key":"10.1016\/j.nbd.2022.105881_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuroscience.2015.04.018","article-title":"Late cortical disinhibition in relaxed versus active hand muscles","volume":"298","author":"Caux-Dedeyst\u00e8re","year":"2015","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.nbd.2022.105881_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2016.04.001","article-title":"Optimal number of pulses as outcome measures of neuronavigated transcranial magnetic stimulation","volume":"127","author":"Chang","year":"2016","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0075","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1152\/jn.00549.2016","article-title":"Modulation of motor cortex inhibition during motor imagery","volume":"117","author":"Chong","year":"2017","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00221-007-1125-7","article-title":"Possible differences between the time courses of presynaptic and postsynaptic GABAB mediated inhibition in the human motor cortex","volume":"184","author":"Chu","year":"2007","journal-title":"Exp. Brain Res."},{"issue":"9","key":"10.1016\/j.nbd.2022.105881_bb0085","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1523\/JNEUROSCI.4989-12.2013","article-title":"GABAB receptors regulate extrasynaptic GABAA receptors","volume":"33","author":"Connelly","year":"2013","journal-title":"J. Neurosci."},{"issue":"6871","key":"10.1016\/j.nbd.2022.105881_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.nbd.2022.105881_bb0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/nn.3546","article-title":"mTOR complexes in neurodevelopmental and neuropsychiatric disorders","volume":"16","author":"Costa-Mattioli","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2022.105881_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(03)00103-9","article-title":"Involvement of cholinergic and gabaergic systems in the fragile X knockout mice","volume":"119","author":"D\u2019Antuono","year":"2003","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.nbd.2022.105881_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABAA receptor: a novel target for treatment of fragile X?","volume":"30","author":"D\u2019Hulst","year":"2007","journal-title":"Trends Neurosci."},{"issue":"C","key":"10.1016\/j.nbd.2022.105881_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","article-title":"Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"1253","author":"D\u2019Hulst","year":"2009","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.nbd.2022.105881_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131486","article-title":"Positron emission tomography (PET) quantification of GABAA receptors in the brain of fragile X patients","volume":"10","author":"D\u2019Hulst","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mri.2015.02.015","article-title":"Noninvasive evaluation of the regional variations of GABA using magnetic resonance spectroscopy at 3 Tesla","volume":"33","author":"Durst","year":"2015","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.nbd.2022.105881_bb0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neuroimage.2017.03.011","article-title":"Comparing GABA-dependent physiological measures of inhibition with proton magnetic resonance spectroscopy measurement of GABA using ultra-high-field MRI","volume":"152","author":"Dyke","year":"2017","journal-title":"NeuroImage"},{"issue":"6","key":"10.1016\/j.nbd.2022.105881_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/mrm.21234","article-title":"In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla","volume":"57","author":"Edden","year":"2007","journal-title":"Magn. Reson. Med."},{"issue":"6","key":"10.1016\/j.nbd.2022.105881_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.24478","article-title":"Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra","volume":"40","author":"Edden","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nbd.2022.105881_bb0145","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00213-019-05344-7","article-title":"The potential of 1 H-MRS in CNS drug development","volume":"238","author":"Egerton","year":"2021","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-013-3022-z","article-title":"Impact of acamprosate on behavior and brain-derived neurotrophic factor: An open-label study in youth with fragile X syndrome","volume":"228","author":"Erickson","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2022.105881_bb0155","first-page":"1","article-title":"Longitudinal assessment of 1H-MRS (GABA and Glx) and TMS measures of cortical inhibition and facilitation in the sensorimotor cortex","author":"Ferland","year":"2019","journal-title":"Exp. Brain Res."},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0160","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2017.19.4\/sscherer","article-title":"Syndromic autism spectrum disorders: Moving from a clinically defined to a molecularly defined approach","volume":"19","author":"Fernandez","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2022.105881_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s00221-001-0988-2","article-title":"Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking","volume":"143","author":"Fisher","year":"2002","journal-title":"Exp. Brain Res."},{"issue":"8","key":"10.1016\/j.nbd.2022.105881_bb0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cub.2017.02.065","article-title":"Reduced lateral inhibition impairs olfactory computations and behaviors in a drosophila model of fragile X syndrome","volume":"27","author":"Franco","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2022.105881_bb0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2014.01.008","article-title":"GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model","volume":"65","author":"Gatto","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105881_bb0180","first-page":"1","article-title":"A perturbed gene network containing PI3KAKT, RASERK and WNT\u03b2-catenin pathways in leukocytes is linked to ASD genetics and symptom severity","author":"Gazestani","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2022.105881_bb0185","first-page":"1","article-title":"Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible","author":"Goel","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41593-018-0273-3","article-title":"Author correction: impaired perceptual learning in a mouse model of fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible","volume":"22","author":"Goel","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2017","key":"10.1016\/j.nbd.2022.105881_bb0195","first-page":"1","article-title":"Testing the excitation\/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes","volume":"47","author":"Gon\u00e7alves","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/j.nbd.2022.105881_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2016.06.007","article-title":"Individual differences in GABA content are reliable but are not uniform across the human cortex","volume":"139","author":"Greenhouse","year":"2016","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bb0205","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1523\/JNEUROSCI.3129-16.2017","article-title":"Individual differences in resting corticospinal excitability are correlated with reaction time and GABA content in motor cortex","volume":"37","author":"Greenhouse","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2022.105881_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.25324","article-title":"GABA quantitation using MEGA-PRESS: Regional and hemispheric differences","volume":"44","author":"Grewal","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0215","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinph.2012.01.010","article-title":"A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee","volume":"123","author":"Groppa","year":"2012","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.24903","article-title":"Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations","volume":"42","author":"Harris","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"issue":"36","key":"10.1016\/j.nbd.2022.105881_bb0225","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1523\/JNEUROSCI.0760-18.2018","article-title":"Brain GABA levels are associated with inhibitory control deficits in older adults","volume":"38","author":"Hermans","year":"2018","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2022.105881_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2018.01.007","article-title":"Acamprosate rescues neuronal defects in the Drosophila model of Fragile X syndrome","volume":"195","author":"Hutson","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0896-6273(01)80053-2","article-title":"GABA(B)-mediated presynaptic inhibition of excitatory transmission and synaptic vesicle dynamics in cultured hippocampal neurons","volume":"18","author":"Isaacson","year":"1997","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.nbd.2022.105881_bb0240","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1074\/jbc.M116.772541","article-title":"Deficits in the activity of presynaptic \u03b3-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome","volume":"292","author":"Kang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105881_bb0245","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.3389\/fnmol.2020.00088","article-title":"Dysregulated prefrontal cortex inhibition in prepubescent and adolescent fragile X mouse model","volume":"13","author":"Kramvis","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0250","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/hbm.21481","article-title":"Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy","volume":"34","author":"Lepage","year":"2011","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0255","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000000884","article-title":"Propofol regulates the surface expression of GABAA receptors: Implications in synaptic inhibition","volume":"121","author":"Li","year":"2015","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J. Neurodev. Disord."},{"issue":"4","key":"10.1016\/j.nbd.2022.105881_bb0265","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-13-131","article-title":"Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1","volume":"13","author":"Mainberger","year":"2013","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bb0275","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00702-016-1609-3","article-title":"Impaired synaptic plasticity in RASopathies: a mini-review","volume":"123","author":"Mainberger","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2022.105881_bb0280","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51440","article-title":"Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission","volume":"9","author":"McCabe","year":"2020","journal-title":"ELife"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s00221-006-0849-0","article-title":"Suppression of LTP-like plasticity in human motor cortex by the GABA B receptor agonist baclofen","volume":"180","author":"McDonnell","year":"2007","journal-title":"Exp. Brain Res."},{"issue":"6","key":"10.1016\/j.nbd.2022.105881_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/jn.00199.2017","article-title":"GABA and primary motor cortex inhibition in young and older adults: a multimodal reliability study","volume":"118","author":"Mooney","year":"2017","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2022.105881_bb0300","first-page":"1","article-title":"Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome","author":"Morin-Parent","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2022.105881_bb0305","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0097-19.2019","article-title":"Lovastatin, not simvastatin, corrects core phenotypes in the fragile X mouse model","volume":"6","author":"Muscas","year":"2019","journal-title":"ENeuro"},{"key":"10.1016\/j.nbd.2022.105881_bb0310","article-title":"Beyond excitation\/inhibition imbalance in multidimensional models of neural circuit changes","author":"O\u2019Donnell","year":"2017","journal-title":"ELife."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0315","first-page":"30","article-title":"Neuromodulation transcranial mag stimulation (TMS)","volume":"3","author":"O\u2019Reardon","year":"2006","journal-title":"Psychiatry (Edgmont)"},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bib431","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.clinph.2008.05.031","article-title":"Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF)","volume":"119","author":"Peurala","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2022.105881_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110307","article-title":"The safety and efficacy of metformin in fragile X syndrome: an open-label study","volume":"110","author":"Proteau-Lemieux","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31825dcf71","article-title":"GABAB-ergic motor cortex dysfunction in SSADH deficiency","volume":"79","author":"Reis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105881_bb0335","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","article-title":"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1","volume":"64","author":"Ribeiro","year":"2015","journal-title":"CORTEX"},{"issue":"3","key":"10.1016\/j.nbd.2022.105881_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s00221-003-1502-9","article-title":"Two phases of short-interval intracortical inhibition","volume":"151","author":"Roshan","year":"2003","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2022.105881_bb0345","first-page":"171","article-title":"Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology","volume":"52","author":"Rossini","year":"1999","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.nbd.2022.105881_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-017-9184-y","article-title":"Acamprosate in a mouse model of fragile X syndrome: Modulation of spontaneous cortical activity, ERK1\/2 activation, locomotor behavior, and anxiety","volume":"9","author":"Schaefer","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.nbd.2022.105881_bb0355","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<736::AID-JNR12>3.0.CO;2-X","article-title":"Elevation of brain GABA levels with vigabatrin (\u03b3-vinylGABA) differentially affects GAD 65 and GAD 67 expression in various regions of rat brain","volume":"52","author":"Sheikh","year":"1998","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.nbd.2022.105881_bb0360","article-title":"GABA Breceptor attenuation of GABA Acurrents in neurons of the mammalian central nervous system","volume":"5","author":"Shen","year":"2017","journal-title":"Phys. Rep."},{"key":"10.1016\/j.nbd.2022.105881_bb0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2015.01.014","article-title":"Evidence for an excitatory GABAA response in human motor cortex in idiopathic generalised epilepsy","volume":"26","author":"Silbert","year":"2015","journal-title":"Seizure: Eur. J. Epilepsy"},{"key":"10.1016\/j.nbd.2022.105881_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2013.01.009","article-title":"Magnetic resonance spectroscopy as a tool to study the role of GABA in motor-cortical plasticity","volume":"86","author":"Stagg","year":"2014","journal-title":"NeuroImage"},{"issue":"23","key":"10.1016\/j.nbd.2022.105881_bb0375","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2011.216978","article-title":"Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex","volume":"589","author":"Stagg","year":"2011","journal-title":"J. Physiol."},{"issue":"17","key":"10.1016\/j.nbd.2022.105881_bb0380","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1212\/WNL.0000000000003868","article-title":"Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome","volume":"88","author":"Stern","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105881_bb0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.nbd.2022.105881_bb0390","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4829-12.2013","article-title":"Postsynaptic GABAB receptors enhance extrasynaptic GABAA receptor function in dentate gyrus granule cells","volume":"33","author":"Tao","year":"2013","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2022.105881_bb0395","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1152\/jn.00704.2012","article-title":"Relationship between transcranial magnetic stimulation measures of intracortical inhibition and spectroscopy measures of GABA and glutamate+glutamine","volume":"109","author":"Tremblay","year":"2013","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.nbd.2022.105881_bb0400","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00221-009-1997-9","article-title":"Interactions between short latency afferent inhibition and long interval intracortical inhibition","volume":"199","author":"Udupa","year":"2009","journal-title":"Exp. Brain Res."},{"issue":"3","key":"10.1016\/j.nbd.2022.105881_bb0405","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/aws368","article-title":"GABA deficit in the visual cortex of patients with neurofibromatosis type 1: genotypephenotype correlations and functional impact","volume":"136","author":"Violante","year":"2013","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.nbd.2022.105881_bb0410","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0000000000003044","article-title":"GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study","volume":"87","author":"Violante","year":"2016","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.nbd.2022.105881_bb0415","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1113\/JP271190","article-title":"GABA Breceptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome","volume":"593","author":"Wahlstrom-Helgren","year":"2015","journal-title":"J. Physiol."},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bb0420","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.clinph.2014.08.028","article-title":"TMS and drugs revisited 2014","volume":"126","author":"Ziemann","year":"2015","journal-title":"Clin. Neurophysiol."},{"issue":"10","key":"10.1016\/j.nbd.2022.105881_bb0425","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ebiom.2015.08.036","article-title":"Impairment of procedural learning and motor intracortical inhibition in neurofibromatosis type 1 patients","volume":"2","author":"Zimerman","year":"2015","journal-title":"EBIOM"},{"key":"10.1016\/j.nbd.2022.105881_bb0430","article-title":"Temporal pattern and synergy influence activity of erk signaling pathways during l-ltp induction","volume":"10","author":"Zobon","year":"2021","journal-title":"ELife"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612200273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612200273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:34:50Z","timestamp":1760852090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612200273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":87,"alternative-id":["S096999612200273X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105881","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105881"}}